Skip Navigation


ToxSci Advance Access originally published online on October 20, 2008
Toxicological Sciences 2009 107(1):40-55; doi:10.1093/toxsci/kfn219
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow All Versions of this Article:
107/1/40    most recent
kfn219v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Naciff, J. M.
Right arrow Articles by Daston, G. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Naciff, J. M.
Right arrow Articles by Daston, G. P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org

The Genomic Response of a Human Uterine Endometrial Adenocarcinoma Cell Line to 17{alpha}-Ethynyl Estradiol

Jorge M. Naciff*,1, Zubin S. Khambatta*, Ryan G. Thomason*, Gregory J. Carr*, Jay P. Tiesman*, David W. Singleton{dagger}, Sohaib A. Khan{dagger} and George P. Daston*

* Miami Valley Innovation Center, The Procter and Gamble Company. Cincinnati, Ohio 45253 {dagger} Department of Cell Biology, Neurobiology, and Anatomy, Vontz Center for Molecular Studies, University of Cincinnati, Cincinnati, Ohio 45267

1 To whom correspondence should be addressed at The Procter and Gamble Company, Miami Valley Innovation Center, P. O. Box 538707 #805, Cincinnati, OH 45253-8707. Fax: (513) 627-0323. E-mail: naciff.jm{at}pg.com.

Received September 29, 2008; accepted October 9, 2008


   Abstract

We have determined the gene expression profile induced by 17 {alpha}-ethynyl estradiol (EE) in Ishikawa cells, a human uterine–derived estrogen-sensitive cell line, at various doses (1pM, 100pM, 10nM, and 1µM) and time points (8, 24, and 48 h). The transcript profiles were compared between treatment groups and controls (vehicle-treated) using high-density oligonucleotide arrays to determine the expression level of approximately 38,500 human genes. By trend analysis, we determined that the expression of 2560 genes was modified by exposure to EE in a dose- and time-dependent manner (p ≤ 0.0001). The annotation available for the genes affected indicates that EE exposure results in changes in multiple molecular pathways affecting various biological processes, particularly associated with development, morphogenesis, organogenesis, cell proliferation, cell organization, and biogenesis. All of these processes are also affected by estrogen exposure in the uterus of the rat. Comparison of the response to EE in both the rat uterus and the Ishikawa cells showed that 71 genes are regulated in a similar manner in vivo as well as in vitro. Further, some of the genes that show a robust response to estrogen exposure in Ishikawa cells are well known to be estrogen responsive, in various in vivo studies, such as PGR, MMP7, IGFBP3, IGFBP5, SOX4, MYC, EGR1, FOS, CKB, and CCND2, among others. These results indicate that transcript profiling can serve as a viable tool to select reliable in vitro systems to evaluate potential estrogenic activities of target chemicals and to identify genes that are relevant for the estrogen response.

Key Words: Ishikawa cells; human uterus; gene expression profiling; microarrays; 17 {alpha}-ethynyl estradiol; in vitro.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.